Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.910
-0.030 (-1.02%)
At close: Dec 16, 2025, 4:00 PM EST
2.890
-0.020 (-0.69%)
After-hours: Dec 16, 2025, 7:21 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $14.34 million as of December 16, 2025. Its market cap has decreased by -65.77% in one year.
Market Cap
14.34M
Enterprise Value
15.23M
1-Year Change
-65.77%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $14.34M, a decrease of -83.83%. That is a compound annual growth rate of -33.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 14.49M | -60.22% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |